Novo Nordisk (NVO.US) launches clinical trial of low-dose oral Wegovy, targeting a broader weight loss population
智通财经2026/08/19 09:01Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Smart Finance APP has learned that Novo Nordisk (NVO.US) is testing a low-dose version of its blockbuster Wegovy oral weight loss drug in a new study. This research will help determine how low the medication dose for patients can be reduced while still achieving weight loss effects.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
US Dollar: Crude rally and CPI risks shape path – BBH
FXStreet•2026/09/08 13:21
Qualcomm offers Amazon up to 25 million stock warrants
智通财经•2026/09/08 13:21
Crypto prices
More
Bitcoin
BTC
$78,210.09
-1.77%
Ethereum
ETH
$2,467.27
-1.57%
Tether USDt
USDT
$0.9996
-0.03%
BNB
BNB
$750.92
+0.50%
XRP
XRP
$1.4
-0.84%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$102.84
-2.70%
TRON
TRX
$0.3390
+1.00%
Hyperliquid
HYPE
$82.8
-5.88%
Zcash
ZEC
$1,157.47
-2.62%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now